Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial to Analyze Clinical and Pharmacological Properties for Severe Neutropenia After Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy Using Mitomycin-C

NCT05513183 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT05513183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05513183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial to Analyze Clinical and Pharmacological Properties for Severe Neutropenia After Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy Using Mitomycin-C
Lead sponsor
Gangnam Severance Hospital
Phase
Observational
Overall status
Completed
Start date
May 20, 2021
Completion date
March 20, 2023
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appendiceal neoplasm, cancer metastatic to the peritoneal cavity, colorectal cancer metastatic, pseudomyxoma peritonei